Recent Updates
Recently added Catalysts
COLL

Collegium to Participate in Upcoming Needham Healthcare Conference

Key Takeaway: STOUGHTON, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will participate in the following investor conference: 21st Annual Needham Virtual Healthc
Price reaction · baseline $20.88 (2022-04-06 close) · hit after-hours · clean, no other COLL news in the window
day 0 close · peak
-1.1%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+28%
120-day peak, hindsight
Typical move
0.4%
average across 3 past catalysts
Lead asset
DFN-15 Active
Phase 3 · Migraine Headache

Full Press Release Details

STOUGHTON, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will participate in the following investor conference:
21st Annual Needham Virtual Healthcare Conference
Virtual fireside chat
Date: Wednesday, April 13, 2022
The fireside chat will be webcast and can be accessed from the Investor section of the Company’s website: https://ir.collegiumpharma.com. A replay of the webcast will be available on the Company’s website for approximately 30 days after the event.
About Collegium Pharmaceutical, Inc.
Collegium is a diversified, specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Last updated: Apr 7, 2022